超声引导下单次前锯肌平面阻滞、竖脊肌平面阻滞及椎旁阻滞对非插管VATS手术镇痛效果和康复的影响:一项随机对照研究

注册号:

Registration number:

ChiCTR1800018204 

最近更新日期:

Date of Last Refreshed on:

2018-10-10 12:45:05 

注册时间:

Date of Registration:

2018-09-05 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

超声引导下单次前锯肌平面阻滞、竖脊肌平面阻滞及椎旁阻滞对非插管VATS手术镇痛效果和康复的影响:一项随机对照研究

Public title:

The Efficacy of Ultrasound-Guided Single Serratus Anterior Plane, Erector Spinae Plane Block and Paravertebral Block on Postoperative Quality of Recovery and Analgesia After Non-intubated Video-Assisted Thoracic Surgery: A Randomized, Controlled Study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

超声引导下单次前锯肌平面阻滞、竖脊肌平面阻滞及椎旁阻滞对非插管VATS手术镇痛效果和康复的影响:一项随机对照研究

Scientific title:

The Efficacy of Ultrasound-Guided Single Serratus Anterior Plane, Erector Spinae Plane Block and Paravertebral Block on Postoperative Quality of Recovery and Analgesia After Non-intubated Video-Assisted Thoracic Surgery: A Randomized, Controlled Study

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

胡柏龙 

研究负责人:

胡柏龙 

Applicant:

Bailong Hu 

Study leader:

Bailong Hu 

申请注册联系人电话:

Applicant telephone:

+86 15185184309

研究负责人电话:

Study leader's
telephone:

+86 15185184309

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

375896605@qq.com

研究负责人电子邮件:

Study leader's E-mail:

375896605@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

贵州省贵阳市云岩区贵医街28号

研究负责人通讯地址:

贵州省贵阳市云岩区贵医街28号

Applicant address:

28 Guiyi Street, Yunyan District, Guiyang, Guizhou, China

Study leader's address:

28 Guiyi Street, Yunyan District, Guiyang, Guizhou, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

贵州医科大学附属医院麻醉科

Applicant's institution:

Tht Department of Anesthesiology, The Affiliated Hospital of Guizhou Medical University

研究负责人所在单位:

贵州医科大学附属医院麻醉科

Affiliation of the Leader:

Tht Department of Anesthesiology, The Affiliated Hospital of Guizhou Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2018-112-1

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

贵州医科大学附属医院药物临床试验伦理委员会

Name of the ethic committee:

Drug Clinical Trials Ethics Committee of The Affiliated Hospital of Guangzhou Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2018-10-09 00:00:00

伦理委员会联系人:

王艺明

Contact Name of the ethic committee:

Wang Yimin

伦理委员会联系地址:

贵州省贵阳市云岩区贵医街28号

Contact Address of the ethic committee:

28 Guiyi Street, Yunyan District, Guiyang, Guizhou, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 0851 86814581

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

贵州医科大学附属医院麻醉科

Primary sponsor:

Tht Department of Anesthesiology, The Affiliated Hospital of Guizhou Medical University

研究实施负责(组长)单位地址:

贵州省贵阳市云岩区贵医街28号

Primary sponsor's address:

28 Guiyi Street, Yunyan District, Guiyang, Guizhou, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

贵州省

市(区县):

Country:

China

Province:

Guizhou

City:

单位(医院):

贵州医科大学附属医院

具体地址:

贵州省贵阳市云岩区贵医街28号

Institution
hospital:

The Affiliated Hospital of Guizhou Medical University

Address:

28 Guiyi Street, Yunyan District, Guiyang, Guizhou, China

经费或物资来源:

自筹经费

Source(s) of funding:

Self financing

研究疾病:

术后疼痛  

Target disease:

Postoperative pain

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

治疗新技术临床试验 

Study phase:

New Treatment Measure Clinical Study

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

对比超声引导下单次前锯肌平面阻滞、竖脊肌平面阻滞和椎旁阻滞对VATS手术镇痛效果和康复的影响,为临床上VATS手术找到更为安全有效的局部镇痛技术。  

Objectives of Study:

Comparison the Efficacy of Ultrasound-Guided Single Serratus Anterior Plane Erector Spinae Plane Block and Paravertebral Block on Postoperative Quality of Recovery and Analgesia After Video-Assisted Thoracic Surgery, aiming to seek out an more effective and safer local analgesia method.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

① 局部穿刺点感染;
② 凝血功能异常;
③ 局麻药过敏;
④ 严重心肺疾病;
⑤ 肝肾功能不全
⑥ 精神疾病
⑦ 术中拟行肺隔离技术者;
⑧ 手术时间预计大于120min者;
⑨ 预计高反流误吸风险者;

Exclusion criteria:

1. Infection of puncture site;
2. dysfunction of blood coagulation;
3. Anaphylaxis of local anesthetic;
4. Severe cardiopulmonary disease;
5. Hepatic and renal insufficiency;
6. mental sickness;
7. Those who need lung isolation intraoperatively;
8. The operation time is expected to be more than 120mn;
9. Those who predicted high risk with reflux and aspiration.

研究实施时间:

Study execute time:

From 2018-09-30 00:00:00 To 2019-09-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2018-09-30 00:00:00 To 2019-09-30 00:00:00

干预措施:

Interventions:

组别:

SAP组

样本量:

30

Group:

SAP group

Sample size:

干预措施:

超声引导下前锯肌平面阻滞

干预措施代码:

Intervention:

ultrasound-guided serratus anterior plane block

Intervention code:

组别:

ESP组

样本量:

30

Group:

ESP group

Sample size:

干预措施:

超声引导下竖脊肌平面阻滞

干预措施代码:

Intervention:

ultrasound-guided erector spinae plane block

Intervention code:

组别:

PVB组

样本量:

30

Group:

PVB group

Sample size:

干预措施:

超声引导下椎旁神经阻滞

干预措施代码:

Intervention:

ultrasound-guided thoracic paravertebral block

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

贵州省 

市(区县):

 

Country:

China

Province:

Guizhou

City:

单位(医院):

贵州医科大学附属医院 

单位级别:

三甲医院 

Institution
hospital:

The Affiliated Hospital of Guizhou Medical University

Level of the institution:

Tertiary A Hospital

测量指标:

Outcomes:

指标中文名:

神经阻滞操作时间

指标类型:

主要指标

Outcome:

Nerve block operation time

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

40项恢复质量评分量表

指标类型:

主要指标

Outcome:

QoR-40

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

视觉模拟评分

指标类型:

主要指标

Outcome:

VRS

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

并发症发生情况

指标类型:

次要指标

Outcome:

the incidence of complications

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血清炎症因子变化

指标类型:

次要指标

Outcome:

the change of serum cytokines

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血流动力学变化

指标类型:

次要指标

Outcome:

Hemodynamic changes

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

镇痛药使用剂量

指标类型:

次要指标

Outcome:

analgesic dose

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

患者满意度

指标类型:

次要指标

Outcome:

Patient satisfaction

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后保存  

说明

Fate of sample:

Preservation after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 65 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

计算机生成的随机数表

Randomization Procedure (please state who generates the random number sequence and by what method):

Computer generated random number table

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Not stated

Blinding:

Not stated

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

试验完成6个月内

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Within six months after the trial complete

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2018-09-05 09:10:58